Cargando…
Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs
BACKGROUND: Significant amount of bone mass is lost during the process of aging due to an imbalance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption in bone marrow microenvironment, which leads to net bone loss in the aging population, resulting in the pathogenesis...
Autores principales: | Chen, Xia, Chen, Junsong, Xu, Dongliang, Zhao, Shuangxia, Song, Huaidong, Peng, Yongde |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658998/ https://www.ncbi.nlm.nih.gov/pubmed/29073887 http://dx.doi.org/10.1186/s12891-017-1779-7 |
Ejemplares similares
-
Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway
por: Hu, Xiang, et al.
Publicado: (2018) -
Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway
por: Xu, Tao, et al.
Publicado: (2019) -
Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis
por: Nulali, Jiayida, et al.
Publicado: (2022) -
The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis
por: Kampmann, Andreas, et al.
Publicado: (2008) -
Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking
por: Tang, Fuyu, et al.
Publicado: (2022)